Skip to main content

Australia Animal Health Central Nervous System Medicines Sales Trend (US$ Million)

Annual sales data for animal health central nervous system medicines, including hypnotics, tranquilizers, emetics and antiemetics used in se...

Market Intelligence Australia 2026
This is a preview. Sign in or create a free account to view the full dataset, chart and data table.
Save

Sign in or create a free account to view this dataset's chart and data table.

Key Takeaway

  • Central nervous system medicines achieved a CAGR of 7% between FY 2019–20 and FY 2024–25. The category covers hypnotics, tranquilizers, emetics and antiemetics used in animal healthcare. The positive growth rate indicates sustained expansion in reported sales over the period.

About This Dataset

Annual sales data for animal health central nervous system medicines, including hypnotics, tranquilizers, emetics and antiemetics used in sedation, behavioural or procedural management, and the control of vomiting. The dataset provides aggregated sales by financial year from 1 July to 30 June.

Methodology

Sign in or create a free account to view this dataset's methodology and sources.

You have subscriber access to this dataset

Available formats: Excel, CSV, PNG, PDF.

A downloadable report hasn't been published for this dataset yet. View Subscription Plans Request Demo
ENTERPRISE ACCESS

Transform Data Into Better Business Decisions

Join organizations that rely on statSCALAR for trusted market intelligence, industry statistics, commodity insights and enterprise research.

View Subscription Plans Request Demo
100+ Industries Included
150+ Countries
50K+ Data Points
24×7 Enterprise Access